Literature DB >> 32125561

Treadmill Exercise Attenuates Aβ-Induced Mitochondrial Dysfunction and Enhances Mitophagy Activity in APP/PS1 Transgenic Mice.

Na Zhao1,2, Qing-Wei Yan3, Jie Xia1,2, Xian-Liang Zhang4, Bai-Xia Li1,2, Ling-Yu Yin1,2, Bo Xu5,6.   

Abstract

Mitochondrial dysfunction is a hallmark of Alzheimer's disease (AD), which may be related to mitophagy failure. Previous reports suggest that treadmill exercise protects against mitochondrial dysfunction in AD. However, few studies have investigated the relationship between mitophagy and mitochondrial adaptation caused by treadmill exercise in AD. The current study aimed to investigate whether exercise-ameliorated AD is associated with changes in mitophagy activity. Both Wild-type and APP/PS1 transgenic mice were divided into sedentary (WTC and ADC) and exercise (WTE and ADE) groups (n = 9 for each group). WTE and ADE mice were subjected to treadmill exercise for 12 weeks, followed by evaluating the effect of treadmill exercise on learning and memory ability, Aβ plaques, mitochondrial Aβ peptide level, synaptic activity and mitochondrial function. Meanwhile, mitophagy-related proteins PINK1, Parkin, LC3II and P62 were measured in the hippocampal mitochondrial fractions. The results indicated that exercise not only restored learning and memory ability, but also reduced Aβ plaque area, mitochondrial Aβ peptide level, and increased levels of synaptic markers SYN and GAP43, as well as reversed mitochondrial dysfunction (defective mitochondrial ultrastructure, decreased PGC-1α, TFAM and ATP levels) in APP/PS1 transgenic mice. Moreover, exercise increased mitophagy activity as evidenced by a significant decrease in levels of P62 and PINK1 as well as an increase in levels of LC3II and Parkin in ADE mice. These findings suggest that treadmill exercise can enhance mitophagy activity in the hippocampus, which is efficient in ameliorating pathological phenotypes of APP/PS1 transgenic mice.

Entities:  

Keywords:  Alzheimer’s disease; Mitochondrial dysfunction; Mitophagy; Treadmill exercise; β-Amyloid

Mesh:

Substances:

Year:  2020        PMID: 32125561     DOI: 10.1007/s11064-020-03003-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  Mitophagy in APPsw/PS1dE9 transgenic mice and APPsw stably expressing in HEK293 cells.

Authors:  X Wang; X-L Zhao; L-L Xu; C-F Wang; L-F Wei; Z Liu; H Yang; P Wang; Z-H Xie; J-Z Bi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-12       Impact factor: 3.507

Review 2.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes.

Authors:  L Holcomb; M N Gordon; E McGowan; X Yu; S Benkovic; P Jantzen; K Wright; I Saad; R Mueller; D Morgan; S Sanders; C Zehr; K O'Campo; J Hardy; C M Prada; C Eckman; S Younkin; K Hsiao; K Duff
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

5.  Increased autophagic degradation of mitochondria in Alzheimer disease.

Authors:  Paula I Moreira; Sandra L Siedlak; Xinglong Wang; Maria S Santos; Catarina R Oliveira; Massimo Tabaton; Akihiko Nunomura; Luke I Szweda; Gjumrakch Aliev; Mark A Smith; Xiongwei Zhu; George Perry
Journal:  Autophagy       Date:  2007-08-14       Impact factor: 16.016

6.  PINK1 signalling rescues amyloid pathology and mitochondrial dysfunction in Alzheimer's disease.

Authors:  Fang Du; Qing Yu; Shijun Yan; Gang Hu; Lih-Fen Lue; Douglas G Walker; Long Wu; Shi Fang Yan; Kim Tieu; Shirley ShiDu Yan
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

7.  Four-month treadmill exercise prevents the decline in spatial learning and memory abilities and the loss of spinophilin-immunoreactive puncta in the hippocampus of APP/PS1 transgenic mice.

Authors:  Lei Zhang; Wei Tang; Feng-Lei Chao; Chun-Ni Zhou; Lin Jiang; Yi Zhang; Xin Liang; Jing Tang; Ying-Qiang Qi; Hao Yang; Qi He; Shan-Shan Zhang; Lin Zhu; Yan Peng; Yong Tang
Journal:  Neurobiol Dis       Date:  2019-12-27       Impact factor: 5.996

Review 8.  Mitophagy: mechanisms, pathophysiological roles, and analysis.

Authors:  Wen-Xing Ding; Xiao-Ming Yin
Journal:  Biol Chem       Date:  2012-07       Impact factor: 3.915

9.  Mitophagy Failure in Fibroblasts and iPSC-Derived Neurons of Alzheimer's Disease-Associated Presenilin 1 Mutation.

Authors:  Patricia Martín-Maestro; Ricardo Gargini; Andrew A Sproul; Esther García; Luis C Antón; Scott Noggle; Ottavio Arancio; Jesús Avila; Vega García-Escudero
Journal:  Front Mol Neurosci       Date:  2017-09-14       Impact factor: 5.639

10.  Dysregulation of Autophagy, Mitophagy, and Apoptotic Genes in the Medial Temporal Lobe Cortex in an Ischemic Model of Alzheimer's Disease.

Authors:  Marzena Ułamek-Kozioł; Janusz Kocki; Anna Bogucka-Kocka; Alicja Petniak; Paulina Gil-Kulik; Sławomir Januszewski; Jacek Bogucki; Mirosław Jabłoński; Wanda Furmaga-Jabłońska; Judyta Brzozowska; Stanisław J Czuczwar; Ryszard Pluta
Journal:  J Alzheimers Dis       Date:  2016-07-27       Impact factor: 4.472

View more
  11 in total

Review 1.  Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches.

Authors:  Arnaud Mary; Fanny Eysert; Frédéric Checler; Mounia Chami
Journal:  Mol Psychiatry       Date:  2022-06-03       Impact factor: 15.992

2.  Curcumin slows the progression of Alzheimer's disease by modulating mitochondrial stress responses via JMJD3-H3K27me3-BDNF axis.

Authors:  Jingna Li; Shanshan Wang; Simiao Zhang; Dan Cheng; Xiaopeng Yang; Yutong Wang; Honglei Yin; Yajun Liu; Yanqiu Liu; Hongying Bai; Shuang Geng; Yunliang Wang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

3.  Establishing Equivalent Aerobic Exercise Parameters Between Early-Stage Parkinson's Disease and Pink1 Knockout Rats.

Authors:  Michael F Salvatore; Isabel Soto; Ella A Kasanga; Rachael James; Marla K Shifflet; Kirby Doshier; Joel T Little; Joshia John; Helene M Alphonso; J Thomas Cunningham; Vicki A Nejtek
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.520

Review 4.  Defective mitophagy and the etiopathogenesis of Alzheimer's disease.

Authors:  Kuan Zeng; Xuan Yu; Yacoubou Abdoul Razak Mahaman; Jian-Zhi Wang; Rong Liu; Yi Li; Xiaochuan Wang
Journal:  Transl Neurodegener       Date:  2022-06-03       Impact factor: 9.883

5.  Treadmill Exercise Improves PINK1/Parkin-Mediated Mitophagy Activity Against Alzheimer's Disease Pathologies by Upregulated SIRT1-FOXO1/3 Axis in APP/PS1 Mice.

Authors:  Na Zhao; Xianliang Zhang; Baixia Li; Jing Wang; Chenfei Zhang; Bo Xu
Journal:  Mol Neurobiol       Date:  2022-10-20       Impact factor: 5.682

6.  Protective effects of mitophagy enhancers against amyloid beta-induced mitochondrial and synaptic toxicities in Alzheimer disease.

Authors:  Sudhir Kshirsagar; Neha Sawant; Hallie Morton; Arubala P Reddy; P Hemachandra Reddy
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

Review 7.  The Toxicity and Polymorphism of β-Amyloid Oligomers.

Authors:  Ya-Ru Huang; Rui-Tian Liu
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

Review 8.  An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?

Authors:  Miriam Sciaccaluga; Alfredo Megaro; Giovanni Bellomo; Gabriele Ruffolo; Michele Romoli; Eleonora Palma; Cinzia Costa
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

9.  Physical exercise may exert its therapeutic influence on Alzheimer's disease through the reversal of mitochondrial dysfunction via SIRT1-FOXO1/3-PINK1-Parkin-mediated mitophagy.

Authors:  Na Zhao; Jie Xia; Bo Xu
Journal:  J Sport Health Sci       Date:  2020-08-28       Impact factor: 7.179

10.  PINK1 Alleviates Cognitive Impairments via Attenuating Pathological Tau Aggregation in a Mouse Model of Tauopathy.

Authors:  Xing Jun Jiang; Yan Qing Wu; Rong Ma; Yan Min Chang; Lu Lu Li; Jia Hui Zhu; Gong Ping Liu; Gang Li
Journal:  Front Cell Dev Biol       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.